Cargando…

Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study

BACKGROUND: Cancer is a significant complication contributing to increased mortality in idiopathic inflammatory myopathies (IIMs), and the association between IIMs and cancer has been extensively reported. Myositis-specific autoantibodies (MSAs) can help to stratify patients into more homogeneous gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hanbo, Peng, Qinglin, Yin, Liguo, Li, Shanshan, Shi, Jingli, Zhang, Yamei, Lu, Xin, Shu, Xiaoming, Zhang, Sigong, Wang, Guochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702134/ https://www.ncbi.nlm.nih.gov/pubmed/29178913 http://dx.doi.org/10.1186/s13075-017-1469-8

Ejemplares similares

Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
por: Yang, Hanbo, et al.
Publicado: (2018)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013)

Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies
por: Perron, Megan Mariko, et al.
Publicado: (2021)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features
por: Yasin, S. A., et al.
Publicado: (2019)

Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies
por: Ghirardello, Anna, et al.
Publicado: (2023)

Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis
por: García-De La Torre, Ignacio
Publicado: (2015)

Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies
por: Ge, Yongpeng, et al.
Publicado: (2015)

Factors Predicting Malignancy in Patients with Polymyositis and Dermatomyostis: A Systematic Review and Meta-Analysis
por: Lu, Xin, et al.
Publicado: (2014)

Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
por: Stuhlmüller, Bruno, et al.
Publicado: (2019)

Narrative review of autoantibodies in idiopathic inflammatory myopathies
por: Liu, Yilin, et al.
Publicado: (2021)

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
por: Betteridge, Z., et al.
Publicado: (2019)

Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies
por: Li, Wenli, et al.
Publicado: (2023)

Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies
por: Li, Mengdi, et al.
Publicado: (2023)

Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience
por: Gudipati, Archana, et al.
Publicado: (2023)

Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy
por: Yu, Zhen, et al.
Publicado: (2021)

Coexistence of Multiple Myositis-Specific Antibodies in Patients with Idiopathic Inflammatory Myopathies
por: Huang, Hung-Ling, et al.
Publicado: (2022)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
por: Chen, Fang, et al.
Publicado: (2022)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2019)

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Yoshifuji, Hajime
Publicado: (2016)

Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies
por: Mageriu, Vlad, et al.
Publicado: (2020)

Autoimmune Idiopathic Inflammatory Myopathies: Pharmacological Differences and Similarities by Type of Myositis and by Sociodemographic Variables
por: Valladales-Restrepo, Luis Fernando, et al.
Publicado: (2022)

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
por: Leclair, Valérie, et al.
Publicado: (2023)

Anti–Valosin‐Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies
por: Amlani, Adam, et al.
Publicado: (2022)

Significance of Myositis Autoantibody in Patients with Idiopathic Interstitial Lung Disease
por: Song, Ju Sun, et al.
Publicado: (2015)

Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy
por: Beam, Michael J., et al.
Publicado: (2023)

Acute Hemorrhagic Myositis in Inflammatory Myopathy and Review of the Literature
por: Van Gelder, Howard, et al.
Publicado: (2014)

Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease?
por: Kiran, Aneeta R., et al.
Publicado: (2016)

A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathies
por: Chen, He, et al.
Publicado: (2020)

Investigating Idiopathic Inflammatory Myopathy; Initial Cross Speciality Experience with Use of the Extended Myositis Antibody Panel
por: O'Connor, Antoinette, et al.
Publicado: (2017)

Profile of specific and associated autoantibodies in patients with idiopathic inflammatory myopathies in a Colombian population
por: Hormaza-Jaramillo, Andrés, et al.
Publicado: (2022)

Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis
por: Li, Liubing, et al.
Publicado: (2020)

Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies
por: Conticini, Edoardo, et al.
Publicado: (2023)

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody
por: Miyamae, Takako, et al.
Publicado: (2018)

Myositis autoantibodies and clinical phenotypes
por: Ghirardello, Anna, et al.
Publicado: (2014)

Resistin in idiopathic inflammatory myopathies
por: Filková, Mária, et al.
Publicado: (2012)

Malignancy and Idiopathic Inflammatory Myopathies
por: Ungprasert, Patompong, et al.
Publicado: (2013)

Idiopathic inflammatory myopathies and the lung
por: Lega, Jean-Christophe, et al.
Publicado: (2015)

Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?
por: Corona-Sanchez, Esther Guadalupe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mp1creuaaae8oud8ebjuoei7c9